View all Courses
Biopharmaceutical Science
Master of Science
Course Details
Course Code | SG_SBIOP_M09 |
---|---|
Level | 9 |
Duration | 2.5 years |
Credits | 90 |
Method of Delivery | Online |
Campus Locations | Sligo |
Mode of Delivery | Part Time |
Course Overview
Course Details
Year 1
Semester | Module Details | Credits | Mandatory / Elective |
---|---|---|---|
1 |
Fermentation and Cell Culture ProcessThis module examines various upstream processing aspects of a typical biopharmaceutical production process. It includes the various design factors that need to be considered for bioprocess design. The primary focus will be on recombinant mammalian cell culture lines with some aspects of microbial lines also included. Learning Outcomes 1. Identify and evaluate the main factors that are involved in the design of an upstream bioprocessing system including which cell line to choose for a particular processing application and the cellline storage conditions cell banking and cell culture scaleup. 2. Outline and evaluate the process kinetics relating to cell growth and productivity for a bioreactor process and the overall impact upon mass transfer balances in a bioreactor for air/oxygen and carbon-dioxide. 3. Identify and interpret the basic mass and energy transfer details for oxygen and carbon dioxide within a bioreactor process. 4. Evaluate and discuss the various designs of bioreactors available and their key features including relative advantages and disadvantages. Also describe the different options for media feeding systems. 5. Describe the main aspects of bioreactor control and operation including the various instrumentation types involved. |
05 | Mandatory |
1 |
Legislation and Regulatory AffairsThis module is taken by Masters students in Pharmaceutical or Biopharmaceutical Science or Engineering. It aims to provide students with a detailed knowledge and understanding of biopharmaceutical legislation in EU and US. It explains the legislation applicable and guidelines available to biopharmaceutical manufacturers. Learning Outcomes 1. Demonstrate they have detailed knowledge and understanding of the global regulatory framework for biotechnology derived products 2. Source and interpret EUDRALEX Volume 2 – \”Pharmaceutical Legislation : Notice to Applicants for Medicinal Products\”. 3. Intergrateknowledge and understanding of the drug development/clinical trial process with the drug approval process for EU and USA 4. Source and interpret procedures and directives currently regulating pharmaceutical production and sales within the EU including product registration, advertising and packaging, good manufacturing, laboratory and clinical practice and pharmocovigilance. 6. Formulate and communicate judgements with regard to regulatory issues for biopharmaceutical products. |
05 | Mandatory |
1 |
Scale-Up and Technology TransferThis module will provide an overview of the regulatory, technical and management issues associated with the scale-up and technology transfer of industrial bioprocesses. The focus will be on giving a clear understanding of the technical and regulatory requirements and approaches necessary to obtain regulatory approval for product scale-up and transfer. It will provide guidance on how to implement efficient and effective projects and will also address such areas as process validation and the typical costs associated with these projects. Learning Outcomes 1. Discuss and evaluate the important process, engineering and regulatory aspects of technology transfer. 3. Provide some practical examples of technology transfer aspects and features. |
05 | Elective |
1 |
Upstream Bioprocessing PracticalThis module covers much of the practical skills associated with cell culture and upstream processing in biopharmaceutical operations. The relevant learning is acquired through the completion of laboratory-based and pilot-plant based practical sessions that are designed to impart the required knowledge and skills required for upstream processing operations. Learning Outcomes 1. Demonstrate a range of practical skills associated with upstream processing in the biopharmaceutical industry. 2. Interpret and evaluate the data and results obtained from various upstream processing practicals. 3. Demonstrate the skills required for upstream bioprocessing operations. 4. Demonstrate effective communication skills. |
05 | Elective |
2 |
Protein Purification ProcessingThis module examines various downstream processing aspects of a typical biopharmaceutical production process. It includes the various design factors that need to be considered for the design of an effective and efficient protein capture and purification process. Learning Outcomes 1. Design an effective and efficient downstream process for a protein capture and purification application. 2. Outline and evaluate the various approaches to primary capture of the target material focusing primarily on affinity chromatography. 4. Interpret and explain other downstream processing technologies such as microfiltration, ultrafiltration, diafiltration, centrifugation, electrophoresis and various viral exclusion techniques. 5. Outline and evaluate the main quality control and analytical techniques required for downstream processing. |
05 | Mandatory |
2 |
Research Methods BiopharmaThe purpose of this module is to complete a research proposal which may subsequently form part of the MSc thesis. Students will have the opportunity to formulate a research topic, develop a research schedule and select appropriate methodologies for a research project. The learner will study different research methods, ethical considerations, learn how to critically analyse scientific documents, disseminate research in terms of reports, and communicate effectively. Learning Outcomes 1. Produce a research proposal document. 2. Undertake a focused literature search and generate a literature review on a research topic. 3. Select and apply an appropriate research methodology while adhering to ethical considerations. 4. Communicate effectively their research outcomes. |
05 | Mandatory |
2 |
Downstream Bioprocessing PracticalThis module covers the practical knowledge and skills required for downstream processing in biopharmaceutical operations. The relevant learning is acquired through the completion of lab-based and pilot-plant based practical sessions that are designed to impart the relevant knowledge and skills required for downstream processing operations. Learning Outcomes 1. Demonstrate a range of practical skills associated with downstream processing operations 2. Interpret and evaluate the data and results obtained from various downstream processing practical sessions. 3. Demonstrate the skills required for upstream bioprocessing operations. 4. Demonstrate effective communication skills. |
05 | Elective |
2 |
Formulation and Delivery SystemsThis module deals with advanced methods of biopharmaceutical formulation for stable drug delivery other than oral dosage forms which are not typically used for biopharmaceuticals. Learning Outcomes 1. Describe the key principles of preformulation. |
05 | Elective |
Year 2
Semester | Module Details | Credits | Mandatory / Elective |
---|---|---|---|
1 |
Biocontamination Monitoring and ControlThis module is taken by Masters students in Pharmaceutical or Biopharmaceutical Science or Engineering. It aims to provide students with a detailed knowledge and understanding of the general principles and methods of Biocontamination control; establishing and verifying the formal system for contamination control and associated test methods and requirements; traditional and modern methods of microbial detection; expressing, interpreting and reporting results; training and documentation requirements. It does this through consideration of basic microbiology, evaluation of relevant microbes, potential sources of microbial contamination, correction/prevention tools, monitoring and detection methods, consideration of all relevant regulations and case study evaluation. Learning Outcomes 1. Discuss and critically evaluate the most relevant microbes for the biopharmaceutical industry and identify and discuss appropriate prevention techniques for each contaminant. 2. Source and interpret the theory behind the detection test methods available, including traditional and rapid identification testing. 3. Develop and justify an appropriate monitoring regime for a pharmaceutical/biopharmaceutical facility. 4. Describe the relevant regulatory expectations for Biocontamination Control including ICH Q8, Q9 and Q10. 5. Perform research on a relevant topic and analyse, evaluate, communicate and explain scientific data relating to biocontamination control. |
05 | Mandatory |
1 |
Bioanalytical TechniquesThis module aims to provide students with a detailed knowledge and understanding of the various analytical test methods used in a biopharmaceutical Quality Control laboratory. The module will focus on the scientific principles behind each method, analytical platforms used and their application in biopharmaceutical analysis. Learning Outcomes 1. LO1) Describe test specifications, CQAs and the routine testing strategies typically employed for analysis of biologics. 2. LO2) Outline and evaluate the main QC test methods and bioanalytical instrumentation routinely employed in the analysis of biologics by sourcing and interpreting the theory behind the methods from a wide range of information sources to demonstrate an in-depth knowledge of the subject matter. 3. LO3 Formulate and communicate judgements with regard to current and emerging biopharmaceutical analytical techniques and instrument platforms. 4. LO4) Develop professional practice skills including time-management, scientific writing and oral communication skills. |
05 | Mandatory |
1 |
Facility Design and OperationThis module will provide students with an overview of the technical and managerial challenges associated with the design and construction of a biopharmaceutical manufacturing facility. It will address all the major elements of these projects from site master planning through conceptual and detailed design and onto commissioning and qualification. It will also cover such associated project aspects as overall planning, budgeting and the organisational systems and structures required to successfully execute such major investments. An overview of how biopharmaceutical manufacturing facilities operate will also be addressed so as the design of the facility from the material and personnel flows through to the process controls and automation, meet the needs of the operations personnel after the facility is brought into production. Learning Outcomes 1. Effectively plan the major elements of an investment in a biopharmaceutical manufacturing facility. 5. Critically evaluatethe principal steps involved in the overall commissioning and qualification of a new or modified biopharmaceutical facility. 6. Appraisethe typical organisational control systems and structures required for biopharmaceutical facility design and operation. |
05 | Elective |
1 |
Bopharmaceutical Analytical Techniques Practical ModuleThis practical module aims to provide specialised knowledge in the theory, practice and interpretation of the various assays and instrumentation routinely employed in a Biopharmaceutical Quality Control laboratory. The necessary skills and competencies will be acquired through a combination of self-study and the completion of a sequence of laboratory-based practicals and demonstrations. Learning Outcomes 1. Outline and evaluate the main quality control and the various assays/tests methods routinely employed in the analysis of biopharmaceuticals. |
05 | Elective |
2 |
Biopharma Process ValidationThe objective of this module is to give students a thorough appreciation of process validation considerations associated with the manufacture of biopharmaceuticals. The approach characterises the process development of a biopharmaceutical from when it progresses from the research entity off the laboratory bench, and forward to the initial clinical trials phase right up through to full scale manufacturing. The focus is on the rational and science based decisions in determining the critical process parameters and quality attributes, and the subsequent setting of the manufacturing operational limits, with the ultimate goal of validating the full scale manufacturing process. Learning Outcomes 1. Describe and critically evaluate process validation considerations for biopharmaceuticals. |
05 | Mandatory |
2 |
Lean Sigma for BioPharmaThis module examines all aspects of the application of Lean Processing and Six Sigma principles to Biopharmaceutical Processing. Learning Outcomes 1. Evaluate and discuss the key principles of Lean Manufacturing and their typical applications for bioprocess industries. 4. Appraise the application of Six Sigma tools such as DMAIC, Process Centering and Variation Reduction, SPC, PCA, QFD, FMEA, Poka-Yoke, HACCP, ANOM, ANOVA. 5. For a typical biopharmaceutical process demonstrate the application of a combination of Lean-Sigma tools for both a core manufacturing process sequence as well for a support function or administrative sequence. |
05 | Mandatory |
2 |
Research Methods BiopharmaThe purpose of this module is to complete a research proposal which may subsequently form part of the MSc thesis. Students will have the opportunity to formulate a research topic, develop a research schedule and select appropriate methodologies for a research project. The learner will study different research methods, ethical considerations, learn how to critically analyse scientific documents, disseminate research in terms of reports, and communicate effectively. Learning Outcomes 1. Produce a research proposal document. 2. Undertake a focused literature search and generate a literature review on a research topic. 3. Select and apply an appropriate research methodology while adhering to ethical considerations. 4. Communicate effectively their research outcomes. |
05 | Elective |
2 |
Project ManagementThis module aims to provide the student with a fundamental understanding of the key elements, phases and tools of Project Management from concept to project completion in order to enable the student to more effectively manage future projects in this industry. Learning Outcomes 1. Identify and discuss the main elements and phases of Project Management from concept to final completion, evaluate the role of the project manager and critique leadership styles. 2. Demonstrate expertise in the preliminary phase of project management including project initiation, risk management, stakeholder identification and communication planning. 3. Critically evaluate the main tools available for successful project progress planning, monitoring and tracking including Gantt charts, work breakdown structures, network diagrams and other resource allocation techniques, cost tracking to budget etc. Apply MS Project or other relevant software. 4. Explain the close-out phase of project management including final commissioning, takeover of facility / process, final contract settlement, formal post-project review and construct lessons learnt. 5. Evaluate project feasibility and synthesise conflict resolution approaches. |
05 | Elective |
2 |
Advanced Technologies in BioprocessingThis module examines the emerging new technologies in the biopharmaceutical industry. It evaluates the current trends towards improved productivity, and also evaluates the increasing diversification in the product pipeline. The practical component of the module covers many of the skills associated with the use of single-use technologies in biopharmaceutical processing. Learning Outcomes 1. Outline and evaluate the key trends towards improved productivity in the biopharmaceutical industry. 2. Describe the challenges of creating a modular, fully single-use facility. 3. Describe the theory and challenges associated with continuous bioprocessing for both upstream and downstream bioprocessing operations. 4. Describe the increasing diversification in the product pipeline, outlining advances in cell therapies, gene therapies, combination products and precision medicines. 5. Demonstrate a range of practical skills associated with single-use technologies used for both upstream and downstream processing operations. |
05 | Elective |
Year 3
Semester | Module Details | Credits | Mandatory / Elective |
---|---|---|---|
Year |
Biopharmaceutical DissertationThis module aims to equip participants with the requisite advanced knowledge, understanding and skills to perform bioprocessing related research using traditional and emerging research designs informed by a critical awareness of developments at the forefront of legislation and practice in the bioprocessing industry. Learning Outcomes 1. Articulate and elaborate an understanding of current thinking on the nature of bioprocessing challenges and the value of related research in that context, whilst showing awareness of the ethical dimensions. 2. Manage a research project combining independent study, support sessions and supervision effectively. 4. Analyse data according to accepted models of analysis, showing awareness of alternative models of analysis and theoretical frameworks.Sustain from the evidence obtained, a reasoned argument and draw consistent and coherent conclusions from the research evidence 5. Reflect self-critically on the significance of the outcomes/conclusions of the enquiry and on the research process itself. 6. Write a dissertation which meets postgraduate standards of technical expertise investigating the subject area or testing the hypothesis outlined in the research proposal. |
30 | Mandatory |
Recommended Study Hours per week
Examination and Assessment
On-Campus Attendance Requirement
Download a prospectus
Entry Requirements
Testimonial
“I completed my undergrad course in 2014 and began my career in diagnostics. In 2018 I heard about springboard and I checked what sort of courses were available; The L9 certificate in biopharmaceutical science in ATU Sligo was completely online which suited me perfectly as it allowed me to continue my career while furthering my learning, so I signed up right away.
It was unbelievably rewarding doing an online course after being out of education for a few years. I found I had a renewed thirst for learning. After 1 year I hadnt had enough, so I signed up for the L9 diploma, and in the autumn of this year I hope to graduate with a masters in biopharmaceutical science.For anyone thinking 1, 2 or 3 years is too long, the best advise I got was “the time passes by anyway whether you are doing the course or not”. And for anyone thinking: Online is not for me… The lectures are so interactive, if you mail lectures or other students in your course, they are more than willing to help out. I have a whole community of support, most of whom I have never met!!
Since starting this course I moved job and am now working within the biopharma sector in the north west of Ireland. I put the things I learned in theory into practice and have fresh perspective on things that I learned during my undergraduate.
For anyone thinking about it, I say go for it!! You will never regret backing yourself or investing in yourself.”
Frances Doherty , MSc in Biopharmaceutical Science – current student
Careers
Further Information
Application Closing Date
Start Date
Contact Information
Admissions Office
T: 071 9318511
E: admissions.sligo@atu.ie
Life Sciences